Tagworks Pharmaceuticals BV, a Netherlands-based pioneer in Click-to-Release chemistry that promotes more effective and safer systemic therapies, has secured $65 million in Series A funding. The investment round, which saw major participation from Spanish venture capital firm Ysios Capital and Gilde Healthcare, along with Novartis Venture Fund, New Enterprise Associates (NEA), and Lightstone Ventures, will […]
Black Diamond Therapeutics, a precision oncology company based in Cambridge, has raised $85 million from a Series C financing round led by Boxer Capital of the Tavistock Group. Additional new investors in the Series C round included Wellington Management Company, BVF Partners, Deerfield Management, funds managed by Janus Henderson Investors, Logos Capital, and Casdin Capital. […]
Mirum Pharmaceuticals, a clinical-stage pharmaceutical company, has successfully raised $120 million in a Series A funding round to propel the development of its lead drug, Maralixibat, aimed at treating rare cholestatic liver diseases. The round was spearheaded by New Enterprise Associates (NEA) and saw participation from other notable investors including Deerfield Management, Frazier Healthcare Partners, […]